Citadel Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-495,358
Closed -$161M – 15779
2024
Q1
$161M Sell
495,358
-395,062
-44% -$97M 0.03% 457
2023
Q4
$170M Buy
890,420
+522,447
+142% +$98.7M 0.03% 419
2023
Q3
$73.3M Buy
367,973
+321,500
+692% +$76M 0.02% 807
2023
Q2
$13.3M Sell
46,473
-115,306
-71% -$32M ﹤0.01% 2332
2023
Q1
$35.1M Sell
161,779
-21,993
-12% -$4.29M 0.01% 1393
2022
Q4
$37.8M Buy
183,772
+80,540
+78% +$20.4M 0.01% 1348
2022
Q3
$28.7M Buy
+103,232
New +$26.3M 0.01% 1520
2022
Q2
– Sell
-48,505
Closed -$8.56M – 14427
2022
Q1
$10.1M Sell
48,505
-37,289
-43% -$6.15M ﹤0.01% 2952
2021
Q4
$15.3M Buy
85,794
+49,723
+138% +$9.8M ﹤0.01% 2385
2021
Q3
$7.43M Sell
36,071
-50,608
-58% -$9.9M ﹤0.01% 3589
2021
Q2
$16.4M Sell
86,679
-27,264
-24% -$4.46M ﹤0.01% 2335
2021
Q1
$14.8M Buy
113,943
+35,836
+46% +$4.3M ﹤0.01% 2380
2020
Q4
$8.1M Sell
78,107
-77,451
-50% -$6.71M ﹤0.01% 2916
2020
Q3
$11.8M Sell
155,558
-336,192
-68% -$19.1M ﹤0.01% 2094
2020
Q2
$23.3M Sell
491,750
-184,582
-27% -$7.6M 0.01% 1385
2020
Q1
$22.4M Buy
676,332
+392,183
+138% +$15.6M 0.01% 1142
2019
Q4
$12.5M Buy
284,149
+112,878
+66% +$4.17M 0.01% 1971
2019
Q3
$5.13M Buy
171,271
+145,771
+572% +$6.19M ﹤0.01% 3078
2019
Q2
$1.46M Sell
25,500
-232,117
-90% -$11.3M ﹤0.01% 5075
2019
Q1
$8.62M Buy
+257,617
New +$8.56M ﹤0.01% 2253

Other funds holding SWAV

Citadel Advisors's SWAV Position: Q2 2024 in Review

Citadel Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 495,358 shares — an estimated $161M sold.

Citadel Advisors first reported a position in SWAV in Q1 2019 and held it in 20 quarters. The position peaked at $170M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Citadel Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 495,358 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $161M.
  • Citadel Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
  • Citadel Advisors's Shockwave Medical, Inc. Common Stock position peaked at $170M in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.